Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03845257
Other study ID # Protocol DG3.0 - 25.06.2018
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date February 14, 2019
Est. completion date January 8, 2020

Study information

Verified date July 2022
Source Heidelberg University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Scientific research focuses on "eosinophilic inflammation" as it seems to guide the therapeutic regimen in patients with asthma and COPD. The primary objective of this prospective trial is to evaluate which parameter(s) best reflects eosinophilic inflammation by correlating tissue eosinophils (endobronchial biopsy, protected specimen brush sampling) with FeNO, peripheral blood eosinophils, and eosinophils in the bronchoalveolar lavage of patients with obstructive pulmonary disease.


Description:

This is a multicenter prospective trial. Enrollment will continue until 150 patients with chronic obstructive pulmonary disease and 50 patients with severe asthma have been entered into this trial and have completed bronchoscopic evaluation. In this trial, the following parameters are to be evaluated: - Blood eosinophils (absolute and relative) - FeNO - Eosinophils in bronchoalveolar lavage - Tissue eosinophilia (protected specimen brush sampling, endobronchial biopsy)


Recruitment information / eligibility

Status Terminated
Enrollment 14
Est. completion date January 8, 2020
Est. primary completion date January 8, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with diagnosis of COPD or asthma (according to the guidelines) - Age >18 years - Indication for bronchoscopy for medical reasons (not study-related) - Ability to provide informed consent Exclusion Criteria: - paO2 <60 mmHg on 4L 02 /min, paCO2 > 55 mmHg on room air - FEV1 <20% - Pulmonary infection or exacerbation within the last 4 weeks - Additional pulmonary diseases (pneumonia, lung cancer, tuberculosis, interstitial lung disease) - Contraindication for BAL, PSB sampling or endobronchial biopsy - Current use of anticoagulants that can not be stopped for bronchoscopy - Heart failure with left ventricular ejection fraction <30% - Myocardial infarction in previous 6 months - Significant pulmonary hypertension (PAPS >45 mmHg, right heart failure [echocardiography] and/or PAPm >35 mmHg [right heart catheter])

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Blood sampling, FeNO, bronchoalveolar lavage, bronchoscopic tissue sampling
Blood sampling (eosinophil count; eosinophilia is defined as >300/µl (or >150/µl during oral glucocorticosteroid treatment); FeNO: Measurement of fractional nitric oxide (NO) concentration in exhaled breath; Bronchoscopy: BAL: total leukocyte counts and leukocyte differential counts including eosinophils, PSB sampling: eosinophil count/100 cells, endobrochial biopsy: tissue eosinophil count/100 cells.

Locations

Country Name City State
Australia Macquarie University Sydney Sydney New South Wales
Germany Division of Clinical Infectious Diseases/Research Center Borstel Borstel
Germany Thoraxklinik University Heidelberg Heidelberg

Sponsors (1)

Lead Sponsor Collaborator
Heidelberg University

Countries where clinical trial is conducted

Australia,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of eosinophilic inflammation by correlating tissue eosinophilia with eosinophil count in blood/BAL and FeNO measurement. Correlation of FeNO, blood eosinophils, bronchoalveolar lavage findings and bronchial epithelium histopathology in patients with chronic obstructive pulmonary disease and asthma 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT05595733 - Can NAVA Mode Reduce Mechanical Ventilation Day in Patients With COPD ? N/A
Completed NCT02506504 - Prevention of Post-exercise Muscle Fatigue and Effect on Exercise Training in Severe Patients With COPD. N/A
Completed NCT02290535 - Electrical Impedance Tomography of Lung in Child and Young Age N/A
Active, not recruiting NCT02073708 - A Population-based Investigation of Asthma in the Telemark Region of Norway